• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion.一条氧化脂质-过氧化物酶体增殖物激活受体γ-趋化因子通路在巨噬细胞与血管平滑肌细胞黏附调节中的作用
Trends Cardiovasc Med. 2007 Nov;17(8):269-74. doi: 10.1016/j.tcm.2007.09.004.
2
Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway.氧化脂质驱动的趋化因子受体转换,从CCR2转换为CX3CR1,通过过氧化物酶体增殖物激活受体γ依赖性途径介导人类巨噬细胞与冠状动脉平滑肌细胞的黏附。
Circulation. 2006 Aug 22;114(8):807-19. doi: 10.1161/CIRCULATIONAHA.105.602359. Epub 2006 Aug 14.
3
Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNFalpha-NFkappaB-dependent manner.致动脉粥样硬化脂质通过以肿瘤坏死因子α-核因子κB依赖的方式上调平滑肌细胞上的趋化因子CX3CL1,诱导人冠状动脉平滑肌细胞与巨噬细胞黏附。
J Biol Chem. 2007 Jun 29;282(26):19167-76. doi: 10.1074/jbc.M701642200. Epub 2007 Apr 23.
4
Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.CX3CL1/CX3CR1和CCL2/CCR2趋化因子系统在低氧性肺动脉高压中的作用
Am J Respir Cell Mol Biol. 2017 May;56(5):597-608. doi: 10.1165/rcmb.2016-0201OC.
5
The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.CC趋化因子MCP-1通过p38丝裂原活化蛋白激酶刺激CX3CR1的表面表达,并增强单核细胞与fractalkine/CX3CL1的黏附。
J Immunol. 2006 Jun 15;176(12):7412-20. doi: 10.4049/jimmunol.176.12.7412.
6
Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma.氧化型低密度脂蛋白通过涉及过氧化物酶体增殖物激活受体γ的途径降低单核细胞CCR2的表达。
J Clin Invest. 2000 Sep;106(6):793-802. doi: 10.1172/JCI10052.
7
Ligands for peroxisome proliferator-activated receptor inhibit monocyte CCR2 expression stimulated by plasma lipoproteins.过氧化物酶体增殖物激活受体的配体可抑制血浆脂蛋白刺激的单核细胞CCR2表达。
Trends Cardiovasc Med. 2000 Jul;10(5):209-16. doi: 10.1016/s1050-1738(00)00076-1.
8
High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.高密度脂蛋白在体外和体内抑制趋化因子和趋化因子受体。
Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1773-8. doi: 10.1161/ATVBAHA.110.211342. Epub 2010 Aug 11.
9
Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL.趋化因子受体CCR2在人单核细胞中的表达及单核细胞趋化蛋白-1介导的趋化作用。血浆低密度脂蛋白的调节作用。
Arterioscler Thromb Vasc Biol. 1998 Dec;18(12):1983-91. doi: 10.1161/01.atv.18.12.1983.
10
Chemokine-chemokine receptor CCL2-CCR2 and CX3CL1-CX3CR1 axis may play a role in the aggravated inflammation in primary biliary cirrhosis.趋化因子-趋化因子受体 CCL2-CCR2 和 CX3CL1-CX3CR1 轴可能在原发性胆汁性肝硬化的炎症加重中发挥作用。
Dig Dis Sci. 2014 Feb;59(2):358-64. doi: 10.1007/s10620-013-2920-6. Epub 2013 Nov 2.

引用本文的文献

1
Stealth missiles with precision guidance: A novel multifunctional nano-drug delivery system based on biomimetic cell membrane coating technology.具有精确制导的隐形导弹:一种基于仿生细胞膜包衣技术的新型多功能纳米药物递送系统。
Mater Today Bio. 2025 May 30;33:101922. doi: 10.1016/j.mtbio.2025.101922. eCollection 2025 Aug.
2
Precision-Guided Stealth Missiles in Biomedicine: Biological Carrier-Mediated Nanomedicine Hitchhiking Strategy.生物医学中的精确制导隐形导弹:生物载体介导的纳米药物搭便车策略。
Adv Sci (Weinh). 2025 Jun;12(21):e2504672. doi: 10.1002/advs.202504672. Epub 2025 May 8.
3
The roles of chemokines following intracerebral hemorrhage in animal models and humans.趋化因子在动物模型和人类脑出血后的作用。
Front Mol Neurosci. 2023 Jan 10;15:1091498. doi: 10.3389/fnmol.2022.1091498. eCollection 2022.
4
Pulmonary vascular dysfunction in metabolic syndrome.代谢综合征中的肺血管功能障碍。
J Physiol. 2019 Feb;597(4):1121-1141. doi: 10.1113/JP275856. Epub 2018 Sep 12.
5
Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis.亚油酸氧化代谢产物作为非酒精性脂肪性肝炎肝损伤的生物标志物
Clin Lipidol. 2013 Aug 1;8(4):411-418. doi: 10.2217/clp.13.39.
6
Homocysteine, Paraoxonase-1 and Vascular Endothelial Dysfunction: Omnibus viis Romam Pervenitur.同型半胱氨酸、对氧磷酶-1与血管内皮功能障碍:条条大路通罗马
J Clin Diagn Res. 2014 Sep;8(9):CE01-4. doi: 10.7860/JCDR/2014/7827.4773. Epub 2014 Sep 20.
7
Peroxisome proliferator-activated receptor agonists modulate neuropathic pain: a link to chemokines?过氧化物酶体增殖物激活受体激动剂调节神经病理性疼痛:与趋化因子有关?
Front Cell Neurosci. 2014 Aug 20;8:238. doi: 10.3389/fncel.2014.00238. eCollection 2014.
8
The downstream regulation of chemokine receptor signalling: implications for atherosclerosis.趋化因子受体信号转导的下游调控:对动脉粥样硬化的影响。
Mediators Inflamm. 2013;2013:459520. doi: 10.1155/2013/459520. Epub 2013 Apr 14.
9
Regulation of atherogenesis by chemokines and chemokine receptors.趋化因子和趋化因子受体对动脉粥样硬化形成的调节作用。
Arch Immunol Ther Exp (Warsz). 2013 Feb;61(1):1-14. doi: 10.1007/s00005-012-0202-1. Epub 2012 Dec 7.
10
Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis.羟基十八碳二烯酸:调节巨噬细胞分化和动脉粥样硬化形成的新型调节剂。
Ther Adv Endocrinol Metab. 2010 Apr;1(2):51-60. doi: 10.1177/2042018810375656.

本文引用的文献

1
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.罗格列酮心血管结局评估——一项中期分析。
N Engl J Med. 2007 Jul 5;357(1):28-38. doi: 10.1056/NEJMoa073394. Epub 2007 Jun 5.
2
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.罗格列酮对心肌梗死风险及心血管原因所致死亡的影响。
N Engl J Med. 2007 Jun 14;356(24):2457-71. doi: 10.1056/NEJMoa072761. Epub 2007 May 21.
3
Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.巨噬细胞特异性过氧化物酶体增殖物激活受体γ控制替代性激活并改善胰岛素抵抗。
Nature. 2007 Jun 28;447(7148):1116-20. doi: 10.1038/nature05894. Epub 2007 May 21.
4
Transmembrane chemokines: versatile 'special agents' in vascular inflammation.跨膜趋化因子:血管炎症中多功能的“特殊因子”
Thromb Haemost. 2007 May;97(5):694-703.
5
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.单核细胞亚群以不同方式利用CCR2、CCR5和CX3CR1在动脉粥样硬化斑块内聚集。
J Clin Invest. 2007 Jan;117(1):185-94. doi: 10.1172/JCI28549.
6
Peroxisome proliferator-activated receptor-gamma agonists for management and prevention of vascular disease in patients with and without diabetes mellitus.过氧化物酶体增殖物激活受体γ激动剂用于治疗和预防糖尿病及非糖尿病患者的血管疾病。
Am J Cardiovasc Drugs. 2006;6(4):231-42. doi: 10.2165/00129784-200606040-00003.
7
Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway.氧化脂质驱动的趋化因子受体转换,从CCR2转换为CX3CR1,通过过氧化物酶体增殖物激活受体γ依赖性途径介导人类巨噬细胞与冠状动脉平滑肌细胞的黏附。
Circulation. 2006 Aug 22;114(8):807-19. doi: 10.1161/CIRCULATIONAHA.105.602359. Epub 2006 Aug 14.
8
The many roles of chemokines and chemokine receptors in inflammation.趋化因子和趋化因子受体在炎症中的多种作用。
N Engl J Med. 2006 Feb 9;354(6):610-21. doi: 10.1056/NEJMra052723.
9
Peroxisome proliferator-activated receptor-gamma activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors.吡格列酮激活过氧化物酶体增殖物激活受体γ可改善伴有主要心血管危险因素的非糖尿病患者的内皮依赖性血管舒张功能。
Circulation. 2006 Feb 14;113(6):867-75. doi: 10.1161/CIRCULATIONAHA.105.549618. Epub 2006 Feb 6.
10
Peroxisome proliferator-activated receptor-alpha,gamma-agonist improves insulin sensitivity and prevents loss of left ventricular function in obese dyslipidemic mice.过氧化物酶体增殖物激活受体α、γ激动剂可改善肥胖血脂异常小鼠的胰岛素敏感性并防止左心室功能丧失。
Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):922-8. doi: 10.1161/01.ATV.0000207318.42066.bb. Epub 2006 Feb 2.

一条氧化脂质-过氧化物酶体增殖物激活受体γ-趋化因子通路在巨噬细胞与血管平滑肌细胞黏附调节中的作用

An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion.

作者信息

Barlic Jana, Murphy Philip M

机构信息

Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Trends Cardiovasc Med. 2007 Nov;17(8):269-74. doi: 10.1016/j.tcm.2007.09.004.

DOI:10.1016/j.tcm.2007.09.004
PMID:18021937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2149843/
Abstract

Recent genetic studies have implicated pro-inflammatory chemokines and chemokine receptors in atherogenesis. Studies at the molecular and cellular levels have suggested specific atherogenic mechanisms for two chemokine-chemokine receptor pairs, CCL2-CCR2 and CX3CL1-CX3CR1, involving differential receptor regulation by the transcription factor peroxisome proliferator-activated receptor gamma. This pathway is triggered by oxidized proatherogenic lipids, such as oxidized low-density lipoprotein and linoleic acid derivatives, which promote differentiation of CCR2(hi)CX3CR1(lo) human monocytes to CCR2(lo)CX3CR1(hi) macrophages that adhere to coronary artery smooth muscle cells in a CX3CR1- and peroxisome proliferator-activated receptor gamma-dependent manner. Switching CX3CR1 on and CCR2 off in vivo may result in cessation of CCR2-dependent migration and activation of CX3CR1-dependent retention that together may promote foam cell accumulation in the vessel wall.

摘要

最近的基因研究表明,促炎趋化因子和趋化因子受体与动脉粥样硬化的发生有关。分子和细胞水平的研究揭示了两种趋化因子-趋化因子受体对(CCL2-CCR2和CX3CL1-CX3CR1)特定的致动脉粥样硬化机制,这涉及转录因子过氧化物酶体增殖物激活受体γ对受体的差异性调控。该途径由促动脉粥样硬化的氧化脂质触发,如氧化型低密度脂蛋白和亚油酸衍生物,它们促进CCR2(hi)CX3CR1(lo)人单核细胞分化为CCR2(lo)CX3CR1(hi)巨噬细胞,这些巨噬细胞以CX3CR1和过氧化物酶体增殖物激活受体γ依赖的方式黏附于冠状动脉平滑肌细胞。体内CX3CR1开启而CCR2关闭可能导致CCR2依赖的迁移停止以及CX3CR1依赖的滞留激活,这两者共同作用可能促进血管壁中泡沫细胞的积聚。